发明名称 PEPTIDE CONJUGATED, INOSINE-SUBSTITUTED ANTISENSE OLIGOMER COMPOUND AND METHOD
摘要 <P>PROBLEM TO BE SOLVED: To provide a therapeutic oligomer-peptide conjugate, and methods of using the conjugate. <P>SOLUTION: The therapeutic oligomer-peptide conjugate includes (a) a substantially uncharged oligonucleotide analog compound having a base sequence that includes a string of bases that are complementary to four or more contiguous cytosine bases in a target nucleic acid region to which the compound is intended to bind, and (b) an arginine-rich peptide, conjugated to the compound, effective to enhance the uptake of the compound into target cells. The string of bases in the compound includes at least one inosine base positioned in the string so as to limit the number of contiguous guanine bases in the string to three or fewer. The conjugate has greater cellular uptake than the compound alone, by virtue of the arginine-rich peptide, and substantially greater antisense activity greater than that of the conjugate in the absence of inosine-for guanine substitutions. <P>COPYRIGHT: (C)2011,JPO&INPIT
申请公布号 JP2011172596(A) 申请公布日期 2011.09.08
申请号 JP20110130577 申请日期 2011.06.10
申请人 AVI BIOPHARMA INC 发明人 IVERSEN PATRICK L;WELLER DWIGHT D;HASSINGER JED N
分类号 C12N15/09;A61K31/7088;A61K47/48;A61K48/00;A61L31/00;A61P9/00;A61P13/12;A61P35/00;C07K4/00;C12N15/11;C12N15/113;C12N15/85 主分类号 C12N15/09
代理机构 代理人
主权项
地址